2010 - TTS International Congress


This page contains exclusive content for the member of the following sections: TTS. Log in to view.

Complications Infections

29.19 - Infectious complications and mortality after renal transplantation

Presenter: Natalya, Tomilina, Moscow, Russian Federation
Authors: Kim I., Tomilina N.

INFECTIOUS COMPLICATIONS AND MORTALITY AFTER RENAL TRANSPLANTATION

COMPLICATIONS - INFECTIONS

I.G. Kim1, N.A. Tomilina2
1Nephrology Problem Of Kifney Transplantation, Reserch Scientific Center of Transplantology and Artificial Organs, Moscow/RUSSIAN FEDERATION, 2Nephrology Problem Of Kifney Transplantation, Reserch Scientific Center of Transplantology, Moscow/RUSSIAN FEDERATION

Body: Infectious complications- one of major causes of mortality after renal transplantation. The aim of the study was to compare frequency and structure of fatal infections in renal graft recipients who received different post-transplant therapy. Materials and methods. We analyzed the data of 2010 recipients who were trasplanted between 1989 and 2006. The patients were divided into 3 groups accoding to recieved therapy. Patients of the 1st group (n=383, transplanted in 1989-1992) and of the 2nd group (n= 479, transplanted in 1995-1997) recieved similar immunosuppression therapy that included prednisolon, azathiorine and cyclosporine. Patients of the 2nd group were also given antiviral therapy (gancyclovir) for cytomegalovirus (CMV) profilaxis. In the 3rd group (n=1148, transplanted in 2002-2006) prednisolon, mycofenolates, calcineirin inhibitors (cyclosporine or tacrolimus) and antiviral therapy were used. Total five-year mortality, frequency and structure of fatal infectious were determined and compared in all groups. Correlation between risk of infectious death at 5 years after transplantation and renal function was also studied. Results. Five-year mortality reduced in last 20 years: 28%,15% and 10% in groups 1,2 and 3, respectively. The share of fatal infections among the total mortality was of 66,7%, 28,7% and 49,7% in groups 1, 2 and 3, respectively. In group1 CMV disease was predominate cause of death (46%), while bacteril infecions caused 13% of deaths. In patients of groups 2 and 3 who recieved antiviral therapy fatal CMV was rare (4% and 18% respectively), but the share of bacteria- fungal and other opportunistic infecions among the total mortality increased (16% и 27%, respectively) compared to in the 1st group. Tuberculosis was responsible for 5%, 1% и 4% of death cases in groups 1, 2 and 3, respectively. Chronic hepatitis B and C caused patients’ death more rarely. The rate of infectious death was higher in patients with renal graft dysfunction. Risk of infectious death at 5 year after transplantation was only 5% in patients with serum Cr level ≤0,13 mmol/l versus 12% in patients with serum Cr level>0,14 mmol/l (p<0,05). Conclusion. Strucrture severe post-transplant infections depends not only on immunosupression therapy, but also on renal function. Systemic fungal and other opportunistic infections are the serious problem after renal transplantation.

Disclosure: All authors have declared no conflicts of interest.


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada